The Opal Health Informatics Group was pleased to partner with the research team of Dr. Bertrand Lebouché to conduct the Opal-COVID study. This study is now complete.
Research team of Dr. Bertrand Lebouché
(+1) 438 822-2004
By participating in the Opal-COVID study, you will be able to:
Self-monitor your symptoms with an
oximeter (and a thermometer if
needed) provided by the research
team and report them via Opal.
Tele-consult with a healthcare
professional if your symptoms
Learn more about COVID-19
and receive counselling.
Opal will help you to reduce your risk and stay in touch with your healthcare team while you are at home.
The Opal app is still in pilot phase and the Opal-COVID study is designed to evaluate its use in monitoring COVID-19 symptoms remotely.